open access

Vol 61, No 2 (2010)
Original papers
Published online: 2010-05-12
Submitted: 2013-02-15
Get Citation

Are plasma ghrelin and PYY concentrations associated with obesity-related depression?

Magdalena Olszanecka-Glinianowicz, Piotr Kocełak, Tomasz Wikarek, Wojciech Gruszka, Piotr Dąbrowski, Jerzy Chudek, Barbara Zahorska-Markiewicz
Endokrynologia Polska 2010;61(2):174-177.

open access

Vol 61, No 2 (2010)
Original papers
Published online: 2010-05-12
Submitted: 2013-02-15

Abstract


Introduction: Recent experimental studies have revealed that increased ghrelin levels protect against depressive symptoms of chronic stress in rats. Moreover it was shown that neuropeptide Y (NPY) has an anxiolytic-like effect mediated through both Y1 and Y5 receptors. On the other hand, peptide YY inhibits, while ghrelin stimulates, the release of NPY. The aim of this study was to assess the association between plasma concentrations of ghrelin and PYY and the level of depression in obese women.
Material and methods: In forty-five obese women (55 ± 7 years old) without concomitant diseases, body composition was estimated by bioimpedance method, in addition to anthropometric measurements. Beck’s Depression Inventory (BDI) was used for the evaluation of depression levels. Plasma concentrations of ghrelin and PYY were measured in collected blood samples.
Results: 23 (55.1%) women had severe (22.0 ± 5.2 pts) and 10 (22.2%) had mild (12.1 ± 1.9 pts) levels of depression. Obese women with concomitant depression were of similar age and had comparable body mass, BMI, and body composition as those without depression. In addition, there were no differences in plasma ghrelin and PYY levels between the study subgroups. No correlation between BDI and plasma concentrations of ghrelin or PYY was found.
Conclusions: Depression in obese women does not seem to be related to the plasma levels of ghrelin and PYY.
(Pol J Endocrinol 2010; 61 (2): 174-177)

Abstract


Introduction: Recent experimental studies have revealed that increased ghrelin levels protect against depressive symptoms of chronic stress in rats. Moreover it was shown that neuropeptide Y (NPY) has an anxiolytic-like effect mediated through both Y1 and Y5 receptors. On the other hand, peptide YY inhibits, while ghrelin stimulates, the release of NPY. The aim of this study was to assess the association between plasma concentrations of ghrelin and PYY and the level of depression in obese women.
Material and methods: In forty-five obese women (55 ± 7 years old) without concomitant diseases, body composition was estimated by bioimpedance method, in addition to anthropometric measurements. Beck’s Depression Inventory (BDI) was used for the evaluation of depression levels. Plasma concentrations of ghrelin and PYY were measured in collected blood samples.
Results: 23 (55.1%) women had severe (22.0 ± 5.2 pts) and 10 (22.2%) had mild (12.1 ± 1.9 pts) levels of depression. Obese women with concomitant depression were of similar age and had comparable body mass, BMI, and body composition as those without depression. In addition, there were no differences in plasma ghrelin and PYY levels between the study subgroups. No correlation between BDI and plasma concentrations of ghrelin or PYY was found.
Conclusions: Depression in obese women does not seem to be related to the plasma levels of ghrelin and PYY.
(Pol J Endocrinol 2010; 61 (2): 174-177)
Get Citation

Keywords

obesity; depression; ghrelin; peptide YY

About this article
Title

Are plasma ghrelin and PYY concentrations associated with obesity-related depression?

Journal

Endokrynologia Polska

Issue

Vol 61, No 2 (2010)

Pages

174-177

Published online

2010-05-12

Bibliographic record

Endokrynologia Polska 2010;61(2):174-177.

Keywords

obesity
depression
ghrelin
peptide YY

Authors

Magdalena Olszanecka-Glinianowicz
Piotr Kocełak
Tomasz Wikarek
Wojciech Gruszka
Piotr Dąbrowski
Jerzy Chudek
Barbara Zahorska-Markiewicz

Important: This website uses cookies.tanya dokter More >>

The cookies allow us to identify your computer and find out details about your last visit. They remembering whether you've visited the site before, so that you remain logged in - or to help us work out how many new website visitors we get each month. Most internet browsers accept cookies automatically, but you can change the settings of your browser to erase cookies or prevent automatic acceptance if you prefer.

Via MedicaWydawcą serwisu jest  "Via Medica sp. z o.o." sp.k., ul. Świętokrzyska 73, 80–180 Gdańsk

tel.:+48 58 320 94 94, faks:+48 58 320 94 60, e-mail:  viamedica@viamedica.pl